EUVIMEDEUVIMED entdecken
Crossref

Factors Associated With Complete Pathologic Necrosis of Hepatocellular Carcinoma on Explant Evaluation After Locoregional Therapy: A National Analysis Using the UNOS Database

Ammar Sarwar, Alan Bonder, Lior Hassan, Muhammad S Malik, Victor Novack, Michael Curry, Muneeb Ahmed

American Journal of Roentgenology · 2023-05 · 220 (5) · 727-735

DOI: 10.2214/ajr.22.28385 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Roentgenology, 2023-05. Verfasst von Ammar Sarwar und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Division of Vascular and Interventional Radiology, Beth Israel Deaconess Medical Center/Harvard Medical School, 1 Deaconess …. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, End Stage Liver Disease, Chemoembolization, Therapeutic. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND. Complete pathologic necrosis (CPN) is associated with improved survival in patients who undergo liver transplant (LT) after locoregional therapy (LRT) for hepatocellular carcinoma (HCC). OBJECTIVE. The purpose of this article was to identify patient, HCC, and transplant center characteristics associated with rates of CPN on explant evaluation using a large national sample of patients undergoing LT after LRT for HCC measuring 3 cm or smaller. METHODS. This retrospective study used data from the United Network for Organ Sharing database. The study included 6265 adults (median age, 62 years; 1505 women, 4760 men) who underwent LT after a single type of LRT (either transarterial chemoembolization [TACE], thermal ablation, or transarterial radioembolization [TARE]) for HCCs measuring 3 cm or smaller at one of 118 U.S. transplant centers from April 12, 2012, to March 31, 2020. Patients were classified as having CPN if explant evaluation showed 100% necrosis of all HCCs. Associations with CPN were explored. Centers were categorized into tertiles on the basis of center-level CPN rates, and tertiles were compared. RESULTS. LRT was performed by TACE in 69.5% (4352/6265), thermal ablation in 19.4% (1217/6265), and TARE in 11.1% (696/6265) of patients. CPN rate was 18.5% (805/4352) after TACE, 35.8% (436/1217) after thermal ablation, 33.6% (234/696) after TARE, and 23.5% (1475/6265) overall. In multivariable analysis incorporating age, sex, model for end-stage liver disease score, α-fetoprotein level before LRT, wait list time, number of HCCs, HCC size, and the transplant center (as a random factor), use of thermal ablation (OR, 2.19; 95% CI, 1.86-2.57; p < .001) or TARE (OR, 1.92; 95% CI, 1.57-2.36; p < .001), with TACE as reference, independently predicted greater likelihood of CPN. Center-level CPN rates ranged from 0.0% to 50.0%. With centers stratified by CPN rates, ablation was performed more frequently than TACE in 5.0% of centers in the first, 15.4% in the second, and 23.1% in the third tertiles (p = .07). CONCLUSION. CPN rate on explant evaluation was low. Thermal ablation or TARE, rather than TACE, was associated with higher likelihood of CPN in patient-level and center-level analyses. CLINICAL IMPACT. Findings from this large national sample support a potential role of thermal ablation or TARE for achieving CPN of HCC measuring 3 cm or smaller.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsEnd Stage Liver DiseaseChemoembolization, TherapeuticMaleAdultHumansFemaleMiddle AgedRetrospective StudiesSeverity of Illness IndexNecrosisTreatment Outcome

Stichwörter der Autor:innen

UNOSablationcomplete pathological necrosishepatocellular carcinoma

Autor:innen und Institutionen

  • Department of Radiology, Division of Vascular and Interventional Radiology, Beth Israel Deaconess Medical Center/Harvard Medical School, 1 Deaconess Rd, Boston, MA 02215.
  • Department of Medicine, Liver Center, Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, MA.
  • Clinical Research Center, Soroka University Medical Center, Beer-Sheva, Israel.
  • Center for Healthcare Delivery Sciences, Beth Israel Deaconess Medical Center, Boston, MA.

Zitieren

APA

Sarwar, A., Bonder, A., Hassan, L., Malik, M. S., Novack, V., Curry, M., & Ahmed, M. (2023). Factors Associated With Complete Pathologic Necrosis of Hepatocellular Carcinoma on Explant Evaluation After Locoregional Therapy: A National Analysis Using the UNOS Database. American Journal of Roentgenology, 220(5), 727-735. https://doi.org/10.2214/ajr.22.28385

Vancouver

Sarwar A, Bonder A, Hassan L, Malik MS, Novack V, Curry M, et al. Factors Associated With Complete Pathologic Necrosis of Hepatocellular Carcinoma on Explant Evaluation After Locoregional Therapy: A National Analysis Using the UNOS Database. American Journal of Roentgenology. 2023;220(5):727-735. doi:10.2214/ajr.22.28385

BibTeX
@article{Sarwar2023,
  author = {Sarwar, Ammar and Bonder, Alan and Hassan, Lior and Malik, Muhammad S and Novack, Victor and Curry, Michael and Ahmed, Muneeb},
  title = {Factors Associated With Complete Pathologic Necrosis of Hepatocellular Carcinoma on Explant Evaluation After Locoregional Therapy: A National Analysis Using the UNOS Database},
  journal = {American Journal of Roentgenology},
  year = {2023},
  volume = {220},
  number = {5},
  pages = {727--735},
  doi = {10.2214/ajr.22.28385}
}
Kostenlos starten →